KIN NASDAQ
Kindred Biosciences, Inc.
1W: +0.2%
1M: +1.9%
3M: +91.5%
1Y: +134.2%
3Y: -37.3%
5Y: +108.3%
$9.25
Last traded 2021-08-27 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$8M
Revenue
-81.4% YoY
$-44M
Net Income
-44.9% YoY
$-30M
Free Cash Flow
-36.0% YoY
81.9%
Gross Margin
-241.6%
Op. Margin
-274.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-52.4%
ROA-38.8%
ROIC-110.5%
Valuation
P/E-15.4
P/B5.4
EV/EBITDA-10.3
Leverage
Debt/Equity0.29
Current Ratio7.02
Interest Cov.-24.1x
Quality Scores
Piotroski F1/9
Altman Z4.77
Beneish M53.66